# name
Treatment of granuloma annulare with tofacitinib

# metadata.dc.description.abstract[].value
Granuloma annulare (GA) is a granulomatous, idiopathic, inflammatory skin disorder characterized by the formation of papules and plaques with annular and acral distribution. GA is often limited and self-resolving, but in some cases, it can be generalized and refractory to treatments. 
New advances in the pathophysiology of GA have favoured Janus kinase (JAK) inhibitors as a promising therapeutic option.1,2 Here, we report three cases of resistant generalized GA successfully treated with tofacitinib.

# metadata.dc.relation.ispartof[].value
Australasian Journal of Dermatology, 2022, vol. 63, num.3, p. 400-403

# metadata.dc.rights[].value
cc-by (c) Bosch Amate, Xavier et al., 2022

# metadata.dc.source[].value
Articles publicats en revistes (Medicina)

# metadata.dc.title[].value
Treatment of granuloma annulare with tofacitinib